Insider · CIK 0001969524
Travis Alan Coy
Files at IMCR (Immunocore Holdings plc), TRXB (TRex Bio, Inc.). First filing -, latest -.
In brief
Travis Alan Coy files SEC Form 4 as CFO and director at IMCR (Immunocore Holdings plc), and also at TRXB (TRex Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Travis Alan Coy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | TRXB TRex Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,500 | $0.00 | $0 | 17,500 | 5 d ago |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +33,353 | $0.00 | $0 | 33,353 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +95,637 | $0.00 | $0 | 95,637 | Feb 19, 2026 |
| Jan 1, 2025 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +274,033 | $0.00 | $0 | 274,033 | Jan 3, 2025 |
Questions about Travis Alan Coy
Answered from the filings on this page, as of the latest one.
Is Travis Alan Coy buying or selling?
Travis Alan Coy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Travis Alan Coy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Travis Alan Coy has 0.
Where does Travis Alan Coy file Form 4?
Travis Alan Coy has filed Form 4 at IMCR (Immunocore Holdings plc) as Chief Financial Officer; TRXB (TRex Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.